Exploring the use of extremity cone beam computed tomography (CBCT) technology in the emergency department (ED) for patients with suspected scaphoid fracture

Improving the Scaphoid Pathway with Extremity CT in the ED: The InSPECTED Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN12548470

Enrollment

260

Registered

2020-04-20

Start date

2020-03-04

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected scaphoid fracture Injury, Occupational Diseases, Poisoning Fracture of navicular [scaphoid] bone of hand

Interventions

All participants will be identified as part of their Emergency Department (ED) attendance for wrist injury, and formally consented for participation in the study. Following clinical assessment by an E

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Present at any of the EDs across the Trust with a mechanism of injury consistent with scaphoid trauma and a positive clinical examination 2. Over the age of 18 and able to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Do not present via the ED 2. Have an additional injury, which may affect the primary outcome measure 3. Evidence that the patient would be unable to adhere to study or procedures or complete questionnaires, for example has cognitive impairment

Design outcomes

Primary

Measure	Time frame
Number of hospital attendances related to the suspected scaphoid fracture measured at the end of the study using patient records.	—

Secondary

Measure	Time frame
Measured using patient records unless otherwise indicated: 1. Number of patients presenting at ED with suspected scaphoid fracture* at baseline 2. Number of patients diagnosed with scaphoid fracture on imaging (prevalence)* at baseline 3. Number and type of imaging investigations (x-rays, CBCT, CT and MRI scans)* at baseline 4. Pathway timings* at baseline 5. Unplanned returns to the ED* at 2 weeks and 6 weeks 6. Planned recalls to the ED* at 2 weeks and 6 weeks 7. ED discharge and referral rates* at baseline 8. CBCT failure rates/delays (patient, technical, staff) at baseline 9. Patient demographics* at baseline 10. Injury demographics including time of presentation, clinical symptoms, injury mechanism and fracture type (if appropriate)* at baseline 11. Patient reported outcome measures (from CRF) at 2 weeks and 6 weeks 11.1. Patient-Rated Wrist Evaluation (PRWE) 11.2. Health Economics/Quality of Life outcomes (EQ-5D-5L) 12. Healthcare resource use at 2 weeks and 6 weeks 13. Radiation dose associated with scaphoid fracture diagnosis / exclusion* at baseline 14. Recruitment rate (assumed consent) 15. Patient baseline CRF (EQ5D-5L and PRWE) completion rates at baseline The data marked with * will also be collected for the retrospective cohort	—

Measure

Time frame

Measured using patient records unless otherwise indicated: 1. Number of patients presenting at ED with suspected scaphoid fracture* at baseline 2. Number of patients diagnosed with scaphoid fracture on imaging (prevalence)* at baseline 3. Number and type of imaging investigations (x-rays, CBCT, CT and MRI scans)* at baseline 4. Pathway timings* at baseline 5. Unplanned returns to the ED* at 2 weeks and 6 weeks 6. Planned recalls to the ED* at 2 weeks and 6 weeks 7. ED discharge and referral rates* at baseline 8. CBCT failure rates/delays (patient, technical, staff) at baseline 9. Patient demographics* at baseline 10. Injury demographics including time of presentation, clinical symptoms, injury mechanism and fracture type (if appropriate)* at baseline 11. Patient reported outcome measures (from CRF) at 2 weeks and 6 weeks 11.1. Patient-Rated Wrist Evaluation (PRWE) 11.2. Health Economics/Quality of Life outcomes (EQ-5D-5L) 12. Healthcare resource use at 2 weeks and 6 weeks 13. Radiation dose associated with scaphoid fracture diagnosis / exclusion* at baseline 14. Recruitment rate (assumed consent) 15. Patient baseline CRF (EQ5D-5L and PRWE) completion rates at baseline The data marked with * will also be collected for the retrospective cohort

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026